Efficacy and safety of S-1 following gemcitabine with cisplatin for advanced biliary tract cancer
Conclusions The efficacy and safety of S-1 following GC were almost the same as those of S-1 following GEM monotherapy for unresectable or recurrent BTC.
Source: Investigational New Drugs - Category: Drugs & Pharmacology Source Type: research
More News: Anemia | Bile | Cancer | Cancer & Oncology | Drugs & Pharmacology | Gallbladder Cancer | Investigational New Drugs | Study | Toxicology